Aqemia is a pioneering pharmatech company dedicated to revolutionizing drug discovery by integrating quantum-inspired physics with advanced machine learning. Established in 2019 as a spin-off from École Normale Supérieure, Aqemia has rapidly developed a robust pipeline of drug discovery projects, aiming to expedite the identification and development of novel therapeutic molecules.